H.R.2338 - To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.114th Congress (2015-2016)
|Sponsor:||Rep. Pitts, Joseph R. [R-PA-16] (Introduced 05/14/2015)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 05/15/2015 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Related Bills: H.R.2338 — 114th Congress (2015-2016)All Information (Except Text)
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.